Year |
Citation |
Score |
2023 |
Chapron SA, Kervran C, Da Rosa M, Fournet L, Shmulewitz D, Hasin D, Denis C, Collombat J, Monsaingeon M, Fatseas M, Gatta-Cherifi B, Serre F, Auriacombe M. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. Drug and Alcohol Dependence. 251: 110937. PMID 37666092 DOI: 10.1016/j.drugalcdep.2023.110937 |
0.769 |
|
2020 |
Kervran C, Shmulewitz D, Serre F, Denis C, Roux P, Jauffret-Roustide M, Lalanne L, Hasin D, Auriacombe M. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. Addictive Behaviors. 116: 106797. PMID 33450665 DOI: 10.1016/j.addbeh.2020.106797 |
0.306 |
|
2020 |
Kervran C, Shmulewitz D, Serre F, Stohl M, Denis C, Hasin D, Auriacombe M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special? Drug and Alcohol Dependence. 212: 108036. PMID 32464467 DOI: 10.1016/J.Drugalcdep.2020.108036 |
0.772 |
|
2019 |
Auriacombe M, Roux P, Briand Madrid L, Kirchherr S, Kervran C, Chauvin C, Gutowski M, Denis C, Carrieri MP, Lalanne L, Jauffret-Roustide M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. Bmj Open. 9: e023683. PMID 30796121 DOI: 10.1136/Bmjopen-2018-023683 |
0.592 |
|
2018 |
Auriacombe M, Moriceau S, Serre F, Denis C, Micoulaud-Franchi JA, de Sevin E, Bonhomme E, Bioulac S, Fatseas M, Philip P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. Drug and Alcohol Dependence. 193: 1-6. PMID 30321739 DOI: 10.1016/J.Drugalcdep.2018.08.025 |
0.776 |
|
2018 |
Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. Addictive Behaviors. PMID 29428330 DOI: 10.1016/J.Addbeh.2018.01.041 |
0.78 |
|
2016 |
Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. Psychiatry Research. PMID 27842945 DOI: 10.1016/J.Psychres.2016.10.071 |
0.772 |
|
2016 |
Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. Substance Abuse. 37: 168-75. PMID 26110463 DOI: 10.1080/08897077.2015.1036334 |
0.799 |
|
2016 |
Auriacombe M, Debrabant R, Kervran C, Serre F, Taillard J, Philip P, Denis C, Fatséas M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point MéDecine Du Sommeil. 13: 91-99. DOI: 10.1016/J.Msom.2016.04.004 |
0.736 |
|
2014 |
Auriacombe M, Denis C, Fatséas M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for? Addiction. 109: 1918-1919. PMID 25297961 DOI: 10.1111/Add.12723 |
0.664 |
|
2014 |
Rennert L, Denis C, Peer K, Lynch KG, Gelernter J, Kranzler HR. DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample. Experimental and Clinical Psychopharmacology. 22: 50-6. PMID 24490711 DOI: 10.1037/A0034518 |
0.398 |
|
2014 |
Debrabant R, Fatseas M, Denis C, Taillard J, Philip P, Auriacombe M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine MéDecine Du Sommeil. 11: 34-35. DOI: 10.1016/J.Msom.2014.01.082 |
0.665 |
|
2013 |
Denis C, Lavie E, Fatseas M, Auriacombe M. WITHDRAWN: Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780682 |
0.759 |
|
2013 |
Denis C, Fatseas M, Lavie E, Auriacombe M. WITHDRAWN: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings The Cochrane Database of Systematic Reviews. 6. PMID 23780681 DOI: 10.1002/14651858.Cd005194.Pub3 |
0.749 |
|
2012 |
Denis C, Fatséas M, Beltran V, Bonnet C, Picard S, Combourieu I, Daulouède JP, Auriacombe M. Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions. Substance Use & Misuse. 47: 356-63. PMID 22216906 DOI: 10.3109/10826084.2011.640732 |
0.607 |
|
2012 |
Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. European Addiction Research. 18: 1-11. PMID 21997500 DOI: 10.1159/000331007 |
0.687 |
|
2012 |
Fatseas M, Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. Aids and Behavior. 16: 2082-90. PMID 21983799 DOI: 10.1007/S10461-011-0054-4 |
0.744 |
|
2012 |
Denis C, Fatséas M, Auriacombe M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria Drug and Alcohol Dependence. 122: 22-27. PMID 21962725 DOI: 10.1016/J.Drugalcdep.2011.09.006 |
0.737 |
|
2011 |
Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biological Psychiatry. 70: 720-7. PMID 21741031 DOI: 10.1016/J.Biopsych.2011.05.015 |
0.715 |
|
2011 |
Denis C, Langlois E, Fatséas M, Auriacombe M, Auriacombe PM. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels Psychotropes. 17: 85. DOI: 10.3917/Psyt.173.0085 |
0.664 |
|
2010 |
Fatséas M, Denis C, Lavie E, Auriacombe M. Relationship between anxiety disorders and opiate dependence- A systematic review of the literature. Implications for diagnosis and treatment Journal of Substance Abuse Treatment. 38: 220-230. PMID 20116963 DOI: 10.1016/J.Jsat.2009.12.003 |
0.775 |
|
2009 |
Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. L'Encephale. 35: 377-85. PMID 19748375 DOI: 10.1016/J.Encep.2008.02.012 |
0.755 |
|
2009 |
Fatséas M, Lavie E, Denis C, Auriacombe M. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients Journal of Substance Abuse Treatment. 37: 407-411. PMID 19339146 DOI: 10.1016/J.Jsat.2009.03.006 |
0.761 |
|
2009 |
Lavie E, Fatséas M, Denis C, Auriacombe M. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence Drug and Alcohol Dependence. 99: 338-344. PMID 18824311 DOI: 10.1016/J.Drugalcdep.2008.07.017 |
0.777 |
|
2008 |
Lavie E, Fatséas M, Daulouède JP, Denis C, Dubernet J, Cattan L, Auriacombe M. Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002. Patient Preference and Adherence. 2: 369-78. PMID 19920984 DOI: 10.2147/Ppa.S4136 |
0.77 |
|
2006 |
Denis C, Lavie E, Fatséas M, Auriacombe M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings Cochrane Database of Systematic Reviews (Online). 3. PMID 16856093 DOI: 10.1002/14651858.Cd005336.Pub2 |
0.784 |
|
2006 |
Denis C, Fatséas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. The Cochrane Database of Systematic Reviews. CD005194. PMID 16856084 DOI: 10.1002/14651858.CD005194.pub2 |
0.776 |
|
2006 |
Fatséas M, Lavie E, Denis C, Franques-Rénéric P, Tignol J, Auriacombe M. [Benzodiazepine withdrawal in subjects on opiate substitution treatment]. Presse Medicale (Paris, France : 1983). 35: 599-606. PMID 16614601 DOI: 10.1016/S0755-4982(06)74647-4 |
0.77 |
|
Show low-probability matches. |